Welcome to the Week in Review.

1. Deflating Big Pharma Lies

 2.  Patients Need Competition To Lower Prices

 3.  Insulin Affordability Crisis

BONUS: P4AD’s David Mitchell was one of several co-authors on this new paper in Nature that examines the ways that universities and academic medical centers, which receive large amounts of funding from taxpayers, can better ensure medicines including novel gene therapies are priced to maximize public health and lessen the burden that high drug prices impose on patients and society.

Have a great weekend!